TRAIL-Resistant Breast Carcinoma
Trail-resistant breast carcinoma is a type of breast cancer that is resistant to treatments that involve TNF-related apoptosis-inducing ligand (TRAIL). This form of cancer is diagnosed when cells are no longer affected by TRAIL-mediated apoptosis, which is a form of cell death. Its significance is that it suggests a decreased response to chemotherapy or other treatments for patients with this form of cancer. Additionally, it can be used as a biomarker to predict the overall prognosis of the cancer. It may also be used to identify more effective treatments and determine the origin of the cancer cells.
← Journal of Breast Cancer Survival